|
|
|
Volumn 142, Issue 19, 1998, Pages 91-100
|
|
Impact of gender on drug responses
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFENTANIL;
ALPRAZOLAM;
ANTIINFECTIVE AGENT;
BROMAZEPAM;
CARDIOVASCULAR AGENT;
CEFEPIME;
CEFOTAXIME;
CLOZAPINE;
CYTOCHROME P450;
DESIPRAMINE;
DIAZEPAM;
DIFLUNISAL;
DIGOXIN;
ERYTHROMYCIN;
FIBRINOLYTIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
LIDOCAINE;
LORAZEPAM;
MIDAZOLAM;
NAPROXEN;
NITRAZEPAM;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
OXAZEPAM;
PARACETAMOL;
PIROXICAM;
SALICYLIC ACID;
TRIAZOLAM;
UNINDEXED DRUG;
VERAPAMIL;
AUTOIMMUNE DISEASE;
CARDIOVASCULAR SYSTEM;
DRUG CLEARANCE;
DRUG EXCRETION;
DRUG HYPERSENSITIVITY;
DRUG PROTEIN BINDING;
DRUG RESPONSE;
DRUG TRANSFORMATION;
FEMALE;
FEMININITY;
GASTROINTESTINAL ABSORPTION;
HUMAN;
MALE;
MASCULINITY;
REVIEW;
SEX DIFFERENCE;
|
|
EID: 0032487459
PISSN: 00126616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (0)
|
